These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 11642202)

  • 1. [Pathogenic factors in diabetic nephropathy. Where do we come from and where are we headed?].
    Marrón B; Ortiz A; Egido J
    Nefrologia; 2001; 21 Suppl 3():18-23. PubMed ID: 11642202
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
    Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH
    Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes, nephropathy, and the renin system.
    Hollenberg NK
    J Hypertens Suppl; 2006 Mar; 24(1):S81-7. PubMed ID: 16601578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prorenin and the renin-angiotensin system in diabetic nephropathy.
    Hsueh WA; Anderson PW
    Semin Nephrol; 1993 Nov; 13(6):573-80. PubMed ID: 8278691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Strategies in prevention, development and progression of diabetic nephropathy].
    Luño J
    Nefrologia; 2005; 25 Suppl 4():48-56. PubMed ID: 16392324
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment].
    Braam B; de Koning EJ; Mees EJ
    Ned Tijdschr Geneeskd; 2004 Jan; 148(5):212-7. PubMed ID: 14983575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephropathy in type 1 diabetes.
    Marre M
    Semin Vasc Med; 2002 Feb; 2(1):97-107. PubMed ID: 16222600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.
    Jacobsen PK; Rossing P; Parving HH
    Nephrol Dial Transplant; 2006 Jul; 21(7):2030-1. PubMed ID: 16449277
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic nephropathy: prevention strategies beyond renin-angiotensin system blockade].
    Romero R; Salinas I
    Nefrologia; 2005; 25 Suppl 4():42-7. PubMed ID: 16392323
    [No Abstract]   [Full Text] [Related]  

  • 17. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Wade VL; Gleason BL
    Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.